1. Home
  2. SPE vs PRQR Comparison

SPE vs PRQR Comparison

Compare SPE & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SPE
  • PRQR
  • Stock Information
  • Founded
  • SPE 1993
  • PRQR 2012
  • Country
  • SPE United States
  • PRQR Netherlands
  • Employees
  • SPE N/A
  • PRQR N/A
  • Industry
  • SPE Finance/Investors Services
  • PRQR Biotechnology: Pharmaceutical Preparations
  • Sector
  • SPE Finance
  • PRQR Health Care
  • Exchange
  • SPE Nasdaq
  • PRQR Nasdaq
  • Market Cap
  • SPE 161.1M
  • PRQR 179.1M
  • IPO Year
  • SPE N/A
  • PRQR 2014
  • Fundamental
  • Price
  • SPE $15.23
  • PRQR $2.14
  • Analyst Decision
  • SPE
  • PRQR Strong Buy
  • Analyst Count
  • SPE 0
  • PRQR 7
  • Target Price
  • SPE N/A
  • PRQR $9.00
  • AVG Volume (30 Days)
  • SPE 25.4K
  • PRQR 297.3K
  • Earning Date
  • SPE 01-01-0001
  • PRQR 08-07-2025
  • Dividend Yield
  • SPE 8.55%
  • PRQR N/A
  • EPS Growth
  • SPE N/A
  • PRQR N/A
  • EPS
  • SPE N/A
  • PRQR N/A
  • Revenue
  • SPE N/A
  • PRQR $21,212,711.00
  • Revenue This Year
  • SPE N/A
  • PRQR N/A
  • Revenue Next Year
  • SPE N/A
  • PRQR N/A
  • P/E Ratio
  • SPE N/A
  • PRQR N/A
  • Revenue Growth
  • SPE N/A
  • PRQR 85.91
  • 52 Week Low
  • SPE $10.26
  • PRQR $1.07
  • 52 Week High
  • SPE $12.59
  • PRQR $4.62
  • Technical
  • Relative Strength Index (RSI)
  • SPE 57.50
  • PRQR 65.11
  • Support Level
  • SPE $14.91
  • PRQR $1.89
  • Resistance Level
  • SPE $15.29
  • PRQR $2.03
  • Average True Range (ATR)
  • SPE 0.12
  • PRQR 0.09
  • MACD
  • SPE -0.02
  • PRQR 0.01
  • Stochastic Oscillator
  • SPE 72.73
  • PRQR 94.74

About SPE Special Opportunities Fund Inc

Special Opportunities Fund Inc is a closed-ended diversified management investment company. Its investment objective is to have the total return. The company's investment portfolio consists of investment companies, common stocks, money market funds, commodity partnerships, preferred stocks, convertible bonds, liquidating trusts, promissory notes, senior unsecured notes, warrants, rights, corporate notes and corporate bonds. In addition, it also makes investments in construction materials, consumer finance, healthcare equipment and supplies, independent power and renewable electricity producers, insurance, personal products, professional services and real estate investment trusts.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: